TEAM - KEN HSU

Dr. Ku-Lung (Ken) Hsu is the founding scientist of Hyku Biosciences. In 2023, Dr. Hsu joined the Department of Chemistry at The University of Texas at Austin as a Cancer Prevention and Research Institute of Texas (CPRIT) Scholar and Endowed Associate Professor, where he is applying his innovative research program in chemical biology to gain basic insights and develop new pharmacological approaches for cancer and immunology. Previously, he was an Associate Professor in the Department of Chemistry at University of Virginia, where he built two major, high-impact research programs: 1) chemistry and chemical biology approaches to decipher the biological roles of proteins involved in the metabolism of lipids and 2) chemical proteomic strategies to expand the druggable proteome through the discovery of sulfonyl-triazoles as covalent binders of tyrosines enabled by sulfur-triazole exchange (SuTEx) chemistry.

Dr. Hsu completed his PhD in Chemistry and Biochemistry from The University of Texas at Austin and was a Hewitt Foundation for Medical Research Postdoctoral Fellow at The Scripps Research Institute (TSRI). At TSRI, Ken gained expertise in activity-based protein profiling (ABPP) and mass spectrometry-based profiling methods to discover and functionally annotate lipid-signaling pathways in inflammation.